期刊
JOURNAL OF THE AMERICAN HEART ASSOCIATION
卷 11, 期 4, 页码 -出版社
WILEY
DOI: 10.1161/JAHA.121.021615
关键词
arrhythmias; defibrillation; induced pluripotent stem cells; models; optical mapping; optogenetics; tissue engineering
资金
- European Research Council [ERC-2017-COG-773181-iPS-ChOp-AF]
- Israel Science Foundation [1088/18]
- Crown Foundation
This study aimed to develop high-resolution optogenetic approaches to modulate electrical activity in 2D and 3D cardiac tissue models derived from human induced pluripotent stem cell cardiomyocytes. The results demonstrated the ability to control the conduction and contractile properties of cardiac cells using optogenetics, and to use light-controllable techniques for cardiac resynchronization therapy and arrhythmia termination. This approach has important applications in cardiac physiology, pathophysiology, and arrhythmia treatment.
Background Optogenetics, using light-sensitive proteins, emerged as a unique experimental paradigm to modulate cardiac excitability. We aimed to develop high-resolution optogenetic approaches to modulate electrical activity in 2- and 3-dimensional cardiac tissue models derived from human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Methods and Results To establish light-controllable cardiac tissue models, opsin-carrying HEK293 cells, expressing the light-sensitive cationic-channel CoChR, were mixed with hiPSC-cardiomyocytes to generate 2-dimensional hiPSC-derived cardiac cell-sheets or 3-dimensional engineered heart tissues. Complex illumination patterns were designed with a high-resolution digital micro-mirror device. Optical mapping and force measurements were used to evaluate the tissues' electromechanical properties. The ability to optogenetically pace and shape the tissue's conduction properties was demonstrated by using single or multiple illumination stimulation sites, complex illumination patterns, or diffuse illumination. This allowed to establish in vitro models for optogenetic-based cardiac resynchronization therapy, where the electrical activation could be synchronized (hiPSC-derived cardiac cell-sheets and engineered heart tissue models) and contractile properties improved (engineered heart tissues). Next, reentrant activity (rotors) was induced in the hiPSC-derived cardiac cell-sheets and engineered heart tissue models through optogenetics programmed- or cross-field stimulations. Diffuse illumination protocols were then used to terminate arrhythmias, demonstrating the potential to study optogenetics cardioversion mechanisms and to identify optimal illumination parameters for arrhythmia termination. Conclusions By combining optogenetics and hiPSC technologies, light-controllable human cardiac tissue models could be established, in which tissue excitability can be modulated in a functional, reversible, and localized manner. This approach may bring a unique value for physiological/pathophysiological studies, for disease modeling, and for developing optogenetic-based cardiac pacing, resynchronization, and defibrillation approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据